|
DENND4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32199999999905E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.66149999999821E-05 |
| Normal-vs-Stage2 |
2.15769999999393E-05 |
| Normal-vs-Stage3 |
1.87549999997039E-06 |
| Normal-vs-Stage4 |
2.430000E-02 |
| Stage1-vs-Stage2 |
2.314800E-01 |
| Stage1-vs-Stage3 |
3.707600E-01 |
| Stage1-vs-Stage4 |
3.132600E-01 |
| Stage2-vs-Stage3 |
6.360800E-01 |
| Stage2-vs-Stage4 |
9.806300E-02 |
| Stage3-vs-Stage4 |
1.548850E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54149999999076E-05 |
| Normal-vs-AfricanAmerican |
2.382400E-03 |
| Normal-vs-Asian |
8.350900E-04 |
| Caucasian-vs-AfricanAmerican |
9.820400E-01 |
| Caucasian-vs-Asian |
9.916200E-01 |
| AfricanAmerican-vs-Asian |
9.877000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.06349999999756E-05 |
| Normal-vs-Female |
2.40059999999653E-05 |
| Male-vs-Female |
9.346400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.035710E-04 |
| Normal-vs-Age(41-60Yrs) |
2.51839999998449E-06 |
| Normal-vs-Age(61-80Yrs) |
1.761670E-03 |
| Normal-vs-Age(81-100Yrs) |
2.034400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.608420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.851400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.280200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.661900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.988200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.950800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.589000E-01 |
| Classical-VS-Follicular |
2.561800E-03 |
| Classical-VS-Other |
2.580200E-01 |
| Classical-VS-Normal |
5.170100E-04 |
| Tall-VS-Follicular |
4.220800E-01 |
| Tall-VS-Other |
5.436400E-01 |
| Tall-VS-Normal |
2.166000E-04 |
| Follicular-VS-Other |
8.874000E-01 |
| Follicular-VS-Normal |
6.64310000009216E-07 |
| Other-VS-Normal |
2.162100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62462999999669E-05 |
| Normal-vs-N1 |
5.984200E-04 |
| N0-vs-N1 |
6.271200E-01 |
|
|
